Stay updated on Crizotinib in ROS1/MET Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Crizotinib in ROS1/MET Lung Cancer Clinical Trial page.

Latest updates to the Crizotinib in ROS1/MET Lung Cancer Clinical Trial page
- Check6 days agoChange DetectedTwo new navigation items, 'Check who can join' and 'Find Contact Information', were added to the page. The release notes show a new version, Revision: v3.6.0, and the previous Revision: v3.5.5 entry was removed.SummaryDifference0.5%

- Check13 days agoChange DetectedA new revision entry (v3.5.5) was added to the study record history, and the previous revision (v3.5.4) was removed from the visible list, reflecting an update to the record's version history.SummaryDifference0.1%

- Check21 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check35 days agoChange DetectedThe revision label in the page footer was updated from v3.5.3 to v3.5.4, indicating a new version of the study record history.SummaryDifference0.1%

- Check49 days agoChange DetectedThe revision in the record history advances from v3.5.2 to v3.5.3, representing a minor update to the page's revision history.SummaryDifference0.1%

- Check63 days agoChange DetectedAdded revision v3.5.2 to the Record History and removed revision v3.5.0.SummaryDifference0.1%

- Check92 days agoChange DetectedRevision v3.5.0 was added and revision v3.4.3 was removed from the record history.SummaryDifference0.1%

Stay in the know with updates to Crizotinib in ROS1/MET Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Crizotinib in ROS1/MET Lung Cancer Clinical Trial page.